Public signalCompany raiseAuto-indexed · Unverified
Immunis, Inc. raised $15.8M
Immunis, Inc.· Irvine, US· Biotechnology· Filed Jul 1, 2024
Immunis, Inc. reported raising capital. Based in Irvine, CALIFORNIA, US. First sale reported 2024-06-17. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$15.8M
Confidence90%
Raised
$15.8M
Investors
18
Jurisdiction
DELAWARE
On the record
- Location
- Irvine, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $15.8M
- Target amount
- $20.0M
- Filing date
- Jul 1, 2024
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Industry group
- Biotechnology
- Number of investors
- 18
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $20.0M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Sources & provenance
“Operating company sold 15,793,916 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Jul 1, 2024. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnology$10M – $100MCompany Raise
Are you associated with Immunis, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record